North America q-PCR Reagents Market – Industry Trends and Forecast to 2029

Market Analysis and Insights: North America q-PCR Reagents Market 

North America q-PCR reagents market is expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses that the market is growing with a CAGR of 7.2% in the forecast period of 2022 to 2029 and is expected to reach USD 673.98 million by 2029. Growth of R&D in the healthcare industry and increase in healthcare expenditure are the major drivers which propelled the demand of the market in the forecast period. Whereas the product recall are restraining the market.

The q-PCR reagents help in the determination of absolute or relative amounts of a known sequence in a sample and are used in different applications such as forensic, research, and diagnostics.

The demand for q-PCR reagents has been increased in both developed well as in developing countries and the reason behind this is the increasing geriatric population and product launch. The q-PCR reagents market is growing due to the introduction of innovative products, increase in technological products, and rising disposable income. The market will grow in the forecasted period due to exploration of emerging markets, strategic initiatives by market players, increasing healthcare expenditure.

Presence of various major market players are providing an opportunity for the market to grow, whereas lack of skilled professionals is challenging for the marker to grow. The q-PCR reagents helps in the determination of absolute or relative amounts of a known sequence in a sample and used in different application such as forensic, research and diagnostics.

The q-PCR reagents market report provides details of market share, new developments, impact of domestic and localized market players analysis of opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

North America q-PCR Reagents Market Scope and Market Size

Q-PCR reagents market is segmented on the based on the basis of the detection type, assay type, plexity, packaging type, application, technology, end user and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

• On the basis of detection type, North America q-PCR reagents market is segmented into dye -based reagents and probe -based reagents. In 2022, probe-based reagents segment is expected to dominate the North America q-PCR reagent market due to its benefits over the dye based such as results that are more exact in lesser time than dye based.
• On the basis of assay type, North America q-PCR reagents market is segmented into qPCR singleplex test/assay and qPCR multiplex test/assay. In 2022, qPCR singleplex test/assay segment is expected to dominate the North America q-PCR reagent market due to the increase in technology for diagnostics tests.
• On the basis of plexity, North America q-PCR reagents market is segmented into dye -based reagents and probe -based reagents. In 2022, dye-based reagents segment is expected to dominate the North America q-PCR reagent market due to increase in healthcare expenditure.
• On the basis of packaging type, North America q-PCR reagents market is segmented into kits and master mixes. In 2022, kits are boosting market growth due to the increasing government spending and disposable income.
• On the basis of technology, North America q-PCR reagents market is segmented into gene expression, gene typing, MIRNA analysis, pre-amplification and virus detection. In 2022, the gene expression segment is expected to dominate the market owing to its credible precision and high-throughput competence.
• On the basis of application, North America q-PCR reagents market is segmented into diagnostics, research and forensic. In 2022, the forensic application is expected to grow at the fastest rate in the market due to increasing R&D activities around U.S.
• On the basis of end user, North America q-PCR reagents market is segmented into hospital & diagnostic centers, forensic laboratories, research & academic institute, clinical research organization, pharmaceutical and biopharmaceutical companies and others. In 2022, the hospital & diagnostic centers segment is expected to dominate the market due to the immense amount of diagnosis and testing required to support a disease discovery and development.
• On the basis of distribution channel, North America q-PCR reagents market is segmented into direct tender third party distributors and others. In 2022, direct tender is expected to dominate the North America q-PCR reagents market as direct tender provides all the products without any secondary medium.

Q-PCR Reagents Market Country Level Analysis

The q-PCR reagents market is analyzed and market size information is provided on the basis of country, detection type, assay type, plexity, packaging type, application, technology, end user and distribution channel.

The countries covered in the q-PCR reagents market report are the U.S., Canada, and Mexico.

Q-PCR reagents segment.in North America region is expected to grow with the highest growth rate in the forecast period of 2022 to 2029 because of increasing research development for enhancing the product quality. U.S is leading the growth of the North America q-PCR reagents market and direct tender segment is dominating in this country due to rising incidence of disease in the country.

The country section of the report also provides individual market affecting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of North America brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Increase in Advancement and Technology for New Product Development are Boosting the Market Growth of q-PCR Reagents

q-PCR reagents market also provides you with detailed market analysis for every country growth in q-PCR reagents industry with q-PCR reagents drugs sales, impact of advancement in the q-PCR reagents technology and changes in regulatory scenarios with their support for the q-PCR reagents market. The data is available for historic period 2010 to 2018.

Competitive Landscape and q-PCR Reagents Market Share Analysis

q-PCR reagents market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breath, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to q-PCR reagents market.

The major companies which are dealing in the North America q-PCR reagents market are Bio-Rad Laboratories, Inc., Agilent Technologies, Inc, Biotium, MiRXES Pte Ltd, GeneDireX, Inc, F. Hoffmann-La Roche Ltd, Norgen Biotek Corp, Takara Holdings Inc., Enzo Biochem Inc, Qiagen, PCR Biosystems, Tonbo Biosciences, Quantabio, Merck KgaA, Kaneka Eurogentec S.A, Promega Corporation, Solis BioDyne, and Seegene Inc among others.

Many product launch and agreement are also initiated by the companies’ worldwide which are also accelerating the q-PCR reagents market.

For instance,

• In November 2021, Biotium announces the release of EvaRuby Dye for qPCR and HRM®. This spectrally unique red fluorescent intercalating dye can be incorporated into probe-based qPCR assays, expanding multiplexing options for probe-based qPCR. This have expanded company’s product portfolio
• In November 2021, Takara Holding Inc., announced the implementation of a manufacturing facility of the Center for Gene and Cell Processing (CGCP) which aims to develop a domestic supply chain for important reagents, including PCR testing reagents. This have increased company’s production and sales

Collaboration, product launch, business expansion, award and recognition, joint ventures and other strategies by the market player is enhancing the company market in the q-PCR reagents market which also provides the benefit for organization to improve their offering for q-PCR reagents.

SKU-67498